We are hiring a Senior Scientist, Drug Metabolism with strong experience in and understanding of ADME studies, for a Study Director level role.
In this position, you will be responsible for part of the studies we perform for our customers. You provide scientific support to our business development team members, plan the scientific and experimental content of the studies together with customers, provide guidance and support to laboratory technicians and scientists, draw conclusions of study results, prepare reports together with our scientists, and confirm the quality of the results and reports in your responsibility area.
You have a university degree in a suitable field of pharmaceutical sciences or chemistry, and an extensive experience and/or doctoral degree in a field related to drug metabolism research. You understand enzymes involved in drug metabolism, master liquid chromatography-mass spectrometry (LC/MS) based analytics of small molecules and are experienced in methods used to investigate metabolic clearance, identification of forming metabolites and to identify drug metabolizing enzymes involved in metabolism of the investigated compounds. Experience in analysis of biological drugs (oligonucleotides or antibodies) is considered as a benefit.
We offer an interesting, versatile, and challenging position in a strongly growing company with a great atmosphere, and many colleagues across our global organization. You will have an opportunity to be part of the constantly evolving drug development landscape and interact directly with the customers in support of their programs. The position is available at our site in Oulu, Finland and it is possible to work remotely part-time.
The position will be filled in spring 2024, as soon as a suitable person is identified.
Please send your application with salary request along with your CV, highlighting the relevant education and work experience to recruitment@admescope.com, with email subject line “Senior Scientist, Drug Metabolism”.
Vacancy is open for EU residents only.
